Project Details
Description
PQ-313-002 “A first in human, double-blind, randomized, intra-subject placebo-controlled, multiple dose study of QR-313 evaluating safety, proof of mechanism, preliminary efficacy and systemic exposure in subjects with Recessive Dystrophic
| Status | Finished |
|---|---|
| Effective start/end date | 7/23/18 → 12/30/22 |
Funding
- PROQR THERAPEUTICS
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.